We are live on ! Find out more
MD icon

Pediatrix Medical

264 hedge funds and large institutions have $1.16B invested in Pediatrix Medical in 2025 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 88 increasing their positions, 90 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 27

10% more funds holding

Funds holding: 241264 (+23)

0.46% more ownership

Funds ownership: 93.41%93.88% (+0.46%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% less capital invested

Capital invested by funds: $1.16B → $1.16B (-$4.09M)

2% less repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 90

Holders
264
Holders Change
+23
Holders Change %
+9.54%
% of All Funds
3.48%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
51
Increased
88
Reduced
90
Closed
27
Calls
$1.2M
Puts
Net Calls
+$1.2M
Net Calls Change
-$1.36M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$200M -$1.07M -78,359 -0.6%
Vanguard Group
2
Vanguard Group
Pennsylvania
$158M +$2.59M +188,590 +2%
State Street
3
State Street
Massachusetts
$50.1M -$502K -36,639 -1%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$47.6M +$2.03M +147,687 +5%
Victory Capital Management
5
Victory Capital Management
Texas
$45.3M +$42.4M +3,090,699 +4,616%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$34.6M -$6.75M -492,421 -17%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$28.7M -$210K -15,298 -0.8%
American Century Companies
8
American Century Companies
Missouri
$27.7M +$5.9M +430,029 +29%
AllianceBernstein
9
AllianceBernstein
Tennessee
$26.4M -$68.8M -5,013,858 -73%
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$22.6M -$4.04M -294,415 -16%
Boston Partners
11
Boston Partners
Massachusetts
$19.9M -$7.71M -562,271 -28%
Morgan Stanley
12
Morgan Stanley
New York
$18.9M -$95.4K -6,958 -0.5%
Charles Schwab
13
Charles Schwab
California
$18.2M +$1.96M +142,991 +13%
Renaissance Technologies
14
Renaissance Technologies
New York
$17.3M -$234K -17,100 -1%
Northern Trust
15
Northern Trust
Illinois
$13.1M -$496K -36,148 -4%
N
16
Nuveen
North Carolina
$12M +$3.92M +285,837 +52%
Goldman Sachs
17
Goldman Sachs
New York
$11.3M +$3.08M +224,789 +40%
CCM
18
Cinctive Capital Management
New York
$11.1M +$10.6M +775,733 New
Pacer Advisors
19
Pacer Advisors
Pennsylvania
$11.1M -$3.02M -220,055 -22%
DIA
20
Dana Investment Advisors
Wisconsin
$10.9M -$160K -11,641 -2%
Ameriprise
21
Ameriprise
Minnesota
$10.7M +$6.5M +474,186 +175%
Qube Research & Technologies (QRT)
22
Qube Research & Technologies (QRT)
United Kingdom
$10.6M +$200K +14,596 +2%
CM
23
CastleKnight Management
New York
$10.1M +$4.01M +292,350 +71%
JP Morgan Chase
24
JP Morgan Chase
New York
$9.85M -$3.38M -246,610 -26%
Prudential Financial
25
Prudential Financial
New Jersey
$9.62M -$1.61M -117,346 -15%

MD Hedge Fund Activity: Q2 2025 in Review

264 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q2 2025, worth a combined $1.16B — down 0.35% from $1.16B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new MD positions and 27 closed out — a net gain of 24 holders — while 88 added to existing stakes and 90 trimmed.

The largest buyer was Victory Capital Management, adding an estimated $42.4M. The largest seller was AllianceBernstein, cutting an estimated $68.8M.

  • 264 institutional investors held Pediatrix Medical (MD) as of Q2 2025, up from 241 in Q1 2025.
  • Funds reported $1.16B of Pediatrix Medical stock for Q2 2025, down 0.35% quarter-over-quarter.
  • 51 funds opened new Pediatrix Medical positions in Q2 2025 and 27 closed out, a net change of +24 holders.
  • The largest Pediatrix Medical buyer in Q2 2025 was Victory Capital Management, an estimated $42.4M added.
  • The largest Pediatrix Medical seller in Q2 2025 was AllianceBernstein, an estimated $68.8M sold.

Based on aggregated 13F filings for Q2 2025.